Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data

International Journal of Cardiology

Volumn 166, Issue 1, 2013, Pages 230-235

  Zhang, Yan ^a   Kilgore, Meredith L ^a   Arora, Tarun ^a   Mujib, Marjan ^a   Ekundayo, O James ^b,c   Aban, Inmaculada B ^a   Feller, Margaret A ^a   Desai, Ravi V ^d   Love, Thomas E ^e   Allman, Richard M ^a,f   Fonarow, Gregg C ^c   Ahmed, Ali ^a,f  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LEHIGH VALLEY HOSPITAL   (United States)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diastolic heart failure; Medicare; Neurohormonal antagonists; OPTIMIZE HF

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; DIASTOLIC HEART FAILURE; DRUG EFFICACY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STUDY DESIGN;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HEART FAILURE, DIASTOLIC; HORMONE ANTAGONISTS; HUMANS; MALE; MEDICARE; MIDDLE AGED; NEURAL INHIBITION; NEUROTRANSMITTER AGENTS; REGISTRIES; TREATMENT OUTCOME; UNITED STATES;

EID: 84877729837     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.10.089     Document Type: Article

References (31)

1. A. Ahmed Chronic heart failure in older adults Med Clin North Am 95 2011 439 461 (ix)
2. M.A. Feller, M. Mujib, and Y. Zhang Baseline characteristics, quality of care, and outcomes of younger and older Medicare beneficiaries hospitalized with heart failure: Findings from the Alabama Heart Failure Project Int J Cardiol 162 1 2012 Dec 15 39 44
3. D.W. Kitzman, W.C. Little, and P.H. Brubaker Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure JAMA 288 2002 2144 2150
4. G.C. Fonarow, W.G. Stough, and W.T. Abraham Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777
5. A. Ahmed, A. Husain, and T.E. Love Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods Eur Heart J 27 2006 1431 1439
6. P.C. Austin Primer on statistical interpretation or methods report card on propensity-score matching in the cardiology literature from 2004 to 2006: a systematic review Circ Cardiovasc Qual Outcomes 1 2008 62 67
7. G. Heinze, and P. Juni An overview of the objectives of and the approaches to propensity score analyses Eur Heart J 32 2011 1704 1708
8. P.R. Rosenbaum, and D.B. Rubin The central role of propensity score in observational studies for causal effects Biometrika 70 1983 41 55
9. D.B. Rubin Using propensity score to help design observational studies: application to the tobacco litigation Health Serv Outcomes Res Methodol 2 2001 169 188
10. B.G. Hammill, A.F. Hernandez, E.D. Peterson, G.C. Fonarow, K.A. Schulman, and L.H. Curtis Linking inpatient clinical registry data to Medicare claims data using indirect identifiers Am Heart J 157 2009 995 1000
11. F.A. Masoudi, E.P. Havranek, and G. Smith Gender, age, and heart failure with preserved left ventricular systolic function J Am Coll Cardiol 41 2003 217 223
12. B.M. Massie, P.E. Carson, and J.J. McMurray Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
13. S. Yusuf, M.A. Pfeffer, and K. Swedberg Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial Lancet 362 2003 777 781
14. A. Ahmed, M.W. Rich, and J.L. Fleg Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial Circulation 114 2006 397 403
15. J.G. Cleland, M. Tendera, and J. Adamus The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 27 2006 2338 2345
16. R.S. Bhatia, J.V. Tu, and D.S. Lee Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
17. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
18. O.J. Ekundayo, C. Adamopoulos, and M.I. Ahmed Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched study Int J Cardiol 141 2010 167 174
19. A. Ahmed, J.B. Young, T.E. Love, R. Levesque, and B. Pitt A propensity-matched study of the effects of chronic diuretic therapy on mortality and hospitalization in older adults with heart failure Int J Cardiol 125 2008 246 253
20. A. Ahmed, B. Pitt, and S.H. Rahimtoola Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial Int J Cardiol 123 2008 138 146
21. M. Gheorghiade, J.D. Flaherty, and G.C. Fonarow Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure Int J Cardiol 151 2011 69 75
22. M.I. Ahmed, M. Lainscak, and M. Mujib Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in women Int J Cardiol 148 2011 36 42
23. B. Pitt, F. Zannad, and M. Gheorghiade Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trial Int J Cardiol 143 2010 309 316
24. G. Giamouzis, S.A. Agha, and O.J. Ekundayo Incident coronary revascularization and subsequent mortality in chronic heart failure: a propensity-matched study Int J Cardiol 140 2010 55 59
25. C. Adamopoulos, B. Pitt, X. Sui, T.E. Love, F. Zannad, and A. Ahmed Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study Int J Cardiol 136 2009 270 277
26. X. Sui, M. Gheorghiade, F. Zannad, J.B. Young, and A. Ahmed A propensity matched study of the association of education and outcomes in chronic heart failure Int J Cardiol 129 2008 93 99
27. O.J. Ekundayo, L.J. Dell'Italia, and P.W. Sanders Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study Int J Cardiol 142 2010 279 287
28. M.I. Ahmed, M. Mujib, and R.V. Desai Outcomes in younger and older adults with chronic advanced systolic heart failure: a propensity-matched study Int J Cardiol 154 2 2012 Jan 26 128 133
29. C. Ritchie, O.J. Ekundayo, and M. Muchimba Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: a propensity-matched study of multimorbidity in chronic heart failure Int J Cardiol 134 2009 330 335
30. A.B. Alper, R.C. Campbell, and S.D. Anker A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure Int J Cardiol 137 2009 1 8
31. L.H. Curtis, M.A. Greiner, and B.G. Hammill Representativeness of a national heart failure quality-of-care registry: comparison of OPTIMIZE-HF and non-OPTIMIZE-HF Medicare patients Circ Cardiovasc Qual Outcomes 2 2009 377 384